» Articles » PMID: 32208465

Variations in Microbiota Composition of Laboratory Mice Influence Citrobacter Rodentium Infection Via Variable Short-chain Fatty Acid Production

Abstract

The composition of the intestinal microbiota influences the outcome of enteric infections in human and mice. However, the role of specific members and their metabolites contributing to disease severity is largely unknown. Using isogenic mouse lines harboring distinct microbiota communities, we observed highly variable disease kinetics of enteric Citrobacter rodentium colonization after infection. Transfer of communities from susceptible and resistant mice into germ-free mice verified that the varying susceptibilities are determined by microbiota composition. The strongest differences in colonization were observed in the cecum and could be maintained in vitro by coculturing cecal bacteria with C. rodentium. Cohousing of animals as well as the transfer of cultivable bacteria from resistant to susceptible mice led to variable outcomes in the recipient mice. Microbiome analysis revealed that a higher abundance of butyrate-producing bacteria was associated with the resistant phenotype. Quantification of short-chain fatty acid (SCFA) levels before and after infection revealed increased concentrations of acetate, butyrate and propionate in mice with delayed colonization. Addition of physiological concentrations of butyrate, but not of acetate and/or propionate strongly impaired growth of C. rodentium in vitro. In vivo supplementation of susceptible, antibiotic-treated and germ-free mice with butyrate led to the same level of protection, notably only when cecal butyrate concentration reached a concentration higher than 50 nmol/mg indicating a critical threshold for protection. In the recent years, commensal-derived primary and secondary bacterial metabolites emerged as potent modulators of hosts susceptibility to infection. Our results provide evidence that variations in SCFA production in mice fed fibre-rich chow-based diets modulate susceptibility to colonization with Enterobacteriaceae not only in antibiotic-disturbed ecosystems but even in undisturbed microbial communities. These findings emphasise the need for microbiota normalization across laboratory mouse lines for infection experiments with the model-pathogen C. rodentium independent of investigations of diet and antibiotic usage.

Citing Articles

Inhibition of Atg7 in intestinal epithelial cells drives resistance against Citrobacter rodentium.

Cune D, Pitasi C, Rubiola A, Jamma T, Simula L, Boucher C Cell Death Dis. 2025; 16(1):112.

PMID: 39971913 PMC: 11840101. DOI: 10.1038/s41419-025-07422-5.


Klebsiella pneumoniae employs a type VI secretion system to overcome microbiota-mediated colonization resistance.

Bray A, Broberg C, Hudson A, Wu W, Nagpal R, Islam M Nat Commun. 2025; 16(1):940.

PMID: 39843522 PMC: 11754592. DOI: 10.1038/s41467-025-56309-8.


Fecal microbiome alterations of mice following immunization with gold nanoparticle vaccines against enterohemorrhagic Escherichia coli.

Bowser S, Chapartegui-Gonzalez I, Torres A Gut Pathog. 2024; 16(1):75.

PMID: 39702387 PMC: 11660674. DOI: 10.1186/s13099-024-00670-4.


Hypusination in intestinal epithelial cells protects mice from infectious colitis.

Gobert A, Hawkins C, Williams K, Snyder L, Barry D, Asim M Gut Microbes. 2024; 16(1):2438828.

PMID: 39673545 PMC: 11649231. DOI: 10.1080/19490976.2024.2438828.


Gut microbiota-derived butyrate selectively interferes with growth of carbapenem-resistant based on their resistance mechanism.

Happ E, Schulze K, Afrin Z, Woltemate S, Gorner P, Ziesing S Gut Microbes. 2024; 16(1):2397058.

PMID: 39292563 PMC: 11529417. DOI: 10.1080/19490976.2024.2397058.


References
1.
Curtis M, Hu Z, Klimko C, Narayanan S, DeBerardinis R, Sperandio V . The gut commensal Bacteroides thetaiotaomicron exacerbates enteric infection through modification of the metabolic landscape. Cell Host Microbe. 2014; 16(6):759-69. PMC: 4269104. DOI: 10.1016/j.chom.2014.11.005. View

2.
Wiles S, Clare S, Harker J, Huett A, Young D, Dougan G . Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cell Microbiol. 2004; 6(10):963-72. DOI: 10.1111/j.1462-5822.2004.00414.x. View

3.
Hiller K, Hangebrauk J, Jager C, Spura J, Schreiber K, Schomburg D . MetaboliteDetector: comprehensive analysis tool for targeted and nontargeted GC/MS based metabolome analysis. Anal Chem. 2009; 81(9):3429-39. DOI: 10.1021/ac802689c. View

4.
Lopez C, Miller B, Rivera-Chavez F, Velazquez E, Byndloss M, Chavez-Arroyo A . Virulence factors enhance Citrobacter rodentium expansion through aerobic respiration. Science. 2016; 353(6305):1249-53. PMC: 5127919. DOI: 10.1126/science.aag3042. View

5.
Turnbaugh P, Hamady M, Yatsunenko T, Cantarel B, Duncan A, Ley R . A core gut microbiome in obese and lean twins. Nature. 2008; 457(7228):480-4. PMC: 2677729. DOI: 10.1038/nature07540. View